Skip to content

Harbin Pharmaceutical Group controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile1 entries

  1. 2011

    Pollution at Harbin Pharmaceutical's General Pharmaceutical Factory exposed and production ordered suspended for rectification

    In 2011, Harbin Pharmaceutical Group's General Pharmaceutical Factory was exposed for waste gas and wastewater pollution problems, involving excessive levels of pollutants such as hydrogen sulfide; regulators ordered suspension of production for rectification. The company responded regarding environmental protection facilities and rectification arrangements; the subject of this entry is the involved general factory and related branch companies.